KYMR - CIK 0001815442
Kymera Therapeutics, Inc. (KYMR) reported revenue of $39.21M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $39.21M | -16.7% |
| FY 2024 | $47.07M | -40.1% |
| FY 2023 | $78.59M | +67.8% |
| FY 2022 | $46.83M | -35.7% |
| FY 2021 | $72.83M | +114.0% |
| FY 2020 | $34.03M | +1060.0% |
| FY 2019 | $2.93M | - |
Kymera Therapeutics, Inc. (KYMR) reported revenue of $39.21M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Kymera Therapeutics, Inc.'s revenue grew from $2.93M to $39.21M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.